Major pharmaceutical companies plan to raise U.S. prices on at least 350 branded medications in 2026 despite pressure from President Trump to lower drug costs 1. The price increases affect high-profile vaccines and blockbuster treatments, potentially impacting investor confidence in the sector’s...